Abbott India informs about disclosure

11 Oct 2023 Evaluate

In terms of Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in view of organizational changes, Abbott India has informed that the Board of Directors has authorized: Vivek V Kamath, Managing Director and Sridhar Kadangode, Chief Financial Officer, severally, for determining materiality of an event or information for the purpose of disclosure and Sangeeta Shetty, Company Secretary, or in her absence, Sridhar Kadangode, Chief Financial Officer, severally, for making disclosure to the Stock Exchange and on Company’s website, as required under the Policy for Determination of Materiality of Event or Information for Disclosure.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

29939.60 465.80 (1.58%)
06-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1846.95
Dr. Reddys Lab 1350.65
Cipla 1490.55
Lupin 2357.75
Zydus Lifesciences 961.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.